Page last updated: 2024-10-27

foscarnet and Genetic Predisposition

foscarnet has been researched along with Genetic Predisposition in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research Excerpts

ExcerptRelevanceReference
"Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis."7.74A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. ( Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK, 2007)
"Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis."3.74A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. ( Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reddy, AJ1
Zaas, AK1
Hanson, KE1
Palmer, SM1

Other Studies

1 other study available for foscarnet and Genetic Predisposition

ArticleYear
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:12

    Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug T

2007